British Columbia Securities Commission

Canadian securities regulators publish next steps to facilitate access to real-time market data

Retrieved on: 
木曜日, 4月 18, 2024

TORONTO, April 18, 2024 /CNW/ - The Canadian Securities Administrators (CSA) today published Staff Notice 21-334 Next Steps to Facilitate Access to Real-Time Market Data (RTMD) which summarizes the comments received to the Consultation Paper published in November 2022, and advises stakeholders of the CSA's next steps to address the access to and use of RTMD.

Key Points: 
  • TORONTO, April 18, 2024 /CNW/ - The Canadian Securities Administrators (CSA) today published Staff Notice 21-334 Next Steps to Facilitate Access to Real-Time Market Data (RTMD) which summarizes the comments received to the Consultation Paper published in November 2022, and advises stakeholders of the CSA's next steps to address the access to and use of RTMD.
  • Real-time market data provides vital information about equity securities markets and its access is key for market participants, investors, and their advisers to make informed investment, routing, and execution decisions.
  • The Alberta Securities Commission and British Columbia Securities Commission expect to review whether to pursue a similar approach for the TSX Venture Exchange.
  • The CSA, the council of the securities regulators of Canada's provinces and territories,
    co-ordinates and harmonizes regulation for the Canadian capital markets.

Reliq Health Technologies, Inc. Provides Update on Status of Management Cease Trade Order

Retrieved on: 
火曜日, 11月 14, 2023

HAMILTON, Ontario, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is providing this update on the status of a management cease trade order granted on October 31, 2023 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203").

Key Points: 
  • HAMILTON, Ontario, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is providing this update on the status of a management cease trade order granted on October 31, 2023 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203").
  • As previously disclosed, we recently completed a private placement to allow the Company to expand its US Operations team.
  • However, the Company's chief executive officer and chief financial officer will not be able to trade in the Company's shares.
  • Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market.

PowerTap Provides Bi-Weekly Status Report

Retrieved on: 
土曜日, 11月 11, 2023

During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.

Key Points: 
  • During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.
  • However, the Company's Chief Executive Office and Chief Financial Officer will not be able to trade in the Company's common shares.
  • Other than as disclosed in this news release, there are no material changes to the information contained in the Default Announcement.
  • The Company confirms that it intends to satisfy the provisions of NP 12- 203 and will continue to issue bi-weekly default status reports for so long as it remains in default of the Annual Filings requirement.

MedMen Provides Annual Filing Status Report

Retrieved on: 
木曜日, 11月 30, 2023

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").

Key Points: 
  • MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").
  • The Company anticipates that the Required Filings will be completed on or before December 13, 2023.
  • The Company has not taken any steps towards any insolvency proceeding and the Company has no material information to release to the public.
  • The Company has made the foregoing representations in accordance with the requirements of applicable securities laws.

New Found Clarifies Technical Disclosure

Retrieved on: 
火曜日, 11月 21, 2023

The Articles have been updated and re-published to correct certain disclosure regarding the Queensway Project at the request of the Company.

Key Points: 
  • The Articles have been updated and re-published to correct certain disclosure regarding the Queensway Project at the request of the Company.
  • The Company retracts the disclosure that was included in the original version of the Articles, including all disclosure regarding an internal scoping study.
  • The Technical Report reflects that neither a mineral resource or preliminary economic assessment have been developed for the Queensway Project.
  • Mr. Matheson certifies that this press release fairly and accurately represents the scientific and technical information that forms the basis for this press release.

MedMen Provides Annual Filing Status Report

Retrieved on: 
木曜日, 11月 16, 2023

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").

Key Points: 
  • MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").
  • The Company anticipates that the Required Filings will be completed on or before December 13, 2023.
  • The Company has not taken any steps towards any insolvency proceeding and the Company has no material information to release to the public.
  • The Company has made the foregoing representations in accordance with the requirements of applicable securities laws.

Liquid Meta Announces Revocation of Cease Trade Order

Retrieved on: 
水曜日, 11月 15, 2023

TORONTO, Nov. 15, 2023 /PRNewswire/ - Liquid Meta Capital Holdings Ltd. ("Liquid Meta" or the "Company") (NEO: LIQD) (FRANKFURT: N5F) (OTCQB: LIQQF) announces that the British Columbia Securities Commission (the "BCSC") has revoked the failure-to-file cease trade order ("FFCTO") issued by the BCSC against the Company and its securities on September 12, 2023 due to the delay in filing its audited annual financial statements, accompanying management discussion and analysis, and CEO and CFO certifications for the financial year ended May 31, 2023 (the "Annual Filings") in accordance with the regulations.

Key Points: 
  • TORONTO, Nov. 15, 2023 /PRNewswire/ - Liquid Meta Capital Holdings Ltd. ("Liquid Meta" or the "Company") (NEO: LIQD) (FRANKFURT: N5F) (OTCQB: LIQQF) announces that the British Columbia Securities Commission (the "BCSC") has revoked the failure-to-file cease trade order ("FFCTO") issued by the BCSC against the Company and its securities on September 12, 2023 due to the delay in filing its audited annual financial statements, accompanying management discussion and analysis, and CEO and CFO certifications for the financial year ended May 31, 2023 (the "Annual Filings") in accordance with the regulations.
  • The revocation of the FFCTO is effective as of November 14, 2023.

Looking Glass Labs Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

Retrieved on: 
水曜日, 11月 1, 2023

The Company has applied for, and has been granted, a management cease trade order (the “MCTO”) by the British Columbia Securities Commission.

Key Points: 
  • The Company has applied for, and has been granted, a management cease trade order (the “MCTO”) by the British Columbia Securities Commission.
  • There are also additional audit procedures required as a result of the nature of the Company's business and its digital asset holdings.
  • During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.
  • However, the Company's chief executive office and chief financial officer will not be able to trade in the Company's common shares.

Reliq Health Technologies, Inc. Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

Retrieved on: 
火曜日, 10月 31, 2023

The Company has applied for, and has been granted, a management cease trade order (the "MCTO") by the British Columbia Securities Commission.

Key Points: 
  • The Company has applied for, and has been granted, a management cease trade order (the "MCTO") by the British Columbia Securities Commission.
  • The Company has been delayed in filing its audited financial statements as it requires more time to complete certain tasks as a result of the Company’s recent private placement offering that closed on October 5, 2023.
  • Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market.
  • Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.

Fobi AI Announces Application for Voluntary MCTO

Retrieved on: 
金曜日, 10月 27, 2023

The MCTO does not affect the ability of other shareholders of the Company to trade in securities of the Company.

Key Points: 
  • The MCTO does not affect the ability of other shareholders of the Company to trade in securities of the Company.
  • Rob Anson, CEO of Fobi AI, states: “Our business is growing and has expanded its operations globally, which has brought about certain complexities.
  • After careful consideration, we have made the decision to file a voluntary MCTO (Management Cease Trade Order) and take proactive measures to safeguard the liquidity of our stock.
  • To download the Fobi Investor Experience Wallet Pass to get enhanced access to investor information about Fobi, please visit our Investor Experience page .